6.02
-0.01 (-0.17%)
| Previous Close | 6.03 |
| Open | 6.04 |
| Volume | 49,475 |
| Avg. Volume (3M) | 98,620 |
| Market Cap | 1,165,599,360 |
| Price / Sales | 22.68 |
| Price / Book | 20.66 |
| 52 Weeks Range | |
| Earnings Date | 27 Jan 2026 |
| Profit Margin | -67.73% |
| Operating Margin (TTM) | -115.65% |
| Diluted EPS (TTM) | -0.080 |
| Quarterly Revenue Growth (YOY) | 40.80% |
| Total Debt/Equity (MRQ) | 25.78% |
| Current Ratio (MRQ) | 3.17 |
| Operating Cash Flow (TTM) | -12.93 M |
| Levered Free Cash Flow (TTM) | -14.06 M |
| Return on Assets (TTM) | -19.93% |
| Return on Equity (TTM) | -55.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | SS Innovations International In | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.13 |
|
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 83.38% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Inspire Investing, Llc | 30 Sep 2025 | 36,887 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 13 Jan 2026 | Announcement | SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025 |
| 08 Jan 2026 | Announcement | SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer |
| 06 Jan 2026 | Announcement | SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets |
| 08 Dec 2025 | Announcement | SS Innovations Submits 510(k) Premarket Notification to the FDA for the Company’s SSi Mantra Surgical Robotic System |
| 06 Nov 2025 | Announcement | SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company’s SSi Mantra Tele Surgeon Console |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |